First published online 27 November 2002
doi: 10.1242/jcs.00216
Evidence of a role for Munc18-2 and microtubules in mast cell granule exocytosis
Sophie Martin-Verdeaux1,
Isabel Pombo1,
Bruno Iannascoli1,
Michèle Roa1,
Nadine Varin-Blank2,
Juan Rivera3 and
Ulrich Blank1,*
1 Unité d'Immuno-Allergie, Institut Pasteur, Paris, France
2 Unité INSERM 363, ICGM, Hôpital Cochin, Paris, France
3 Molecular Inflammation Section, National Institute of Arthritis and
Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD
20892, USA

View larger version (29K):
[in a new window]
|
Fig. 1. Characterisation of Munc18 isoforms in mast cells. (A) Some Munc18 isoforms
are expressed in RBL cells. Total brain (1 µg) and RBL cell lysates
(2x 105 cell equivalents) were resolved on SDS-PAGE,
transferred to nitrocellulose and probed with antibodies to Munc18-1 (1/1000),
Munc18-2 or Munc18-3 (all at 1 µg/ml). (B) Munc18-2 and Munc18-3 are
expressed in mast cell lines or primary mast cells. Lysates of RBL, C57.1,
BMMC and MCP-5/L cells were resolved on SDS-PAGE, transferred to
nitrocellulose and probed with anti-Munc18-2 or Munc18-3.
|
|

View larger version (42K):
[in a new window]
|
Fig. 2. Interaction of Munc18 isoforms with syntaxins. (A) Proteins from RBL cell
lysates were immunoprecipitated with antibodies (5 µg) to syntaxin 2, 3 or
4. Immunoprecipitates were resolved on SDS-PAGE and immunoblotted with
antibodies to Munc18-2 or Munc18-3 (upper panel) or with antibodies to
syntaxin 2, 3 and 4 (lower panel) (all at 1 µg/ml). (B) Proteins from RBL
cell lysates were immunoprecipitated with antibodies (5 µg) to Munc18-2 or
GST control, resolved on SDS-PAGE and immunoblotted with antibodies to
syntaxin 2, 3 and 4 (upper panel) and Munc18-2 (lower panel).
|
|

View larger version (87K):
[in a new window]
|
Fig. 3. Localisation of Munc18 and syntaxins isoforms. (A) Co-localisation with PM
marker. RBL cells were seeded overnight on glass coverslips. After
permeabilisation, cells were incubated with antibody to Fc RI ß
chain (1 µg/ml) as a PM marker and either antibodies to Munc18-2, Munc18-3,
syntaxin 3 or syntaxin 4 (all at 2 µg/ml). Cells were visualised by
confocal microscopy as described in Materials and Methods. Single optical
sections through individual cells as well as the merge (green and red
fluorescence) from several cells are presented. In the inset of the upper
panel the green and red fluorescence are superimposed to the DIC image. Arrows
highlight area of red fluorescence in cellular protrusions. (B)
Co-localisation with a SG marker. RBL cells were treated as above before
incubation with antibody to RMCP II (1/500) as a SG marker, and antibodies to
either Munc18-2 or syntaxin 3 (all at 2 µg/ml). For BMMCs, cells were
allowed to adhere to L-polylysine-coated coverslips for 1 hour before staining
with antibody to serotonin (1/50) as a SG marker, and antibodies to either
Munc18-2 or syntaxin 3. Cells were visualised by confocal microscopy as
described in Materials and Methods. Single optical sections through individual
cells are presented. For BMMCs only the merge (green and red fluorescence) is
shown. Bars, 5 µm. Images are representative of at least three
experiments.
|
|

View larger version (69K):
[in a new window]
|
Fig. 5. Role of the cytoskeleton in Munc18-2 polarisation. RBL cells seeded on
coverslips were treated with cytochalasin D (10 µM) or vehicles for 30
minutes (A) and nocodazole (33 µM) or vehicle for 1 hour (B) prior to
incubation with antibodies to Munc18-2 (red fluorescence) and phalloidin-FITC
(green fluorescence) or with antibodies to Munc18-2 (red) and -tubulin
and RMCP II (both in green) as indicated. Cells were visualised by confocal
microscopy as described in Materials and Methods. The merged images (green and
red fluorescence) are shown, except for RMCP II staining, which is
superimposed to the DIC image. Bars, 5 µm. Images are representative of at
least three experiments. Note that the less focalised appearance of Munc18-2
staining in A is probably due to the solvent used for cell treatment. The
nuclear appearance of Munc18-2 in nocodazole-treated cells in B (right panel)
is caused by a low signal to noise ratio following redistribution of Munc18-2
to a diffuse staining pattern.
|
|

View larger version (29K):
[in a new window]
|
Fig. 6. Effect of cytoskeleton-perturbing agents on secretion (A) and Munc18-2
relocation (B). (A) RBL cells were seeded in 96-well plates and sensitised
overnight with IgE. Cells were treated with the indicated concentrations of
either cytochalasin D for 30 minutes or nocodazole for 1 hour, or
corresponding vehicles prior to stimulation with DNP-HSA. Released SG content
was determined by ß-hexosminidase release. (B) RBL cells seeded on
coverslips were incubated with either cytochalasin D (10 µM) for 1 hour,
nocodazole (33 µM) for 1 hour or EGTA (5 mM) for 15 minutes before
stimulation with DNP-HSA for 10 minutes. Cells were processed for confocal
analysis and probed with antibodies to Munc18-2 (red) and either
phalloidin-FITC (green) or antibody to -tubulin (green) as before.
Cells were visualised by confocal microscopy as described in Materials and
Methods. The merged images (green and red fluorescence) of several, as well as
single cells are shown. As after treatment with cytochalasin D phalloidin
staining is decreased, presentation of an overlay of the DIC image with
Munc18-2 staining is preferred. Note also that after nocodazole-treatment MT
staining either disappears (single cell panel) or is severely restricted to
the MTOC. Bars, 5 µm. Images are representative of at least three
experiments.
|
|
© The Company of Biologists Ltd 2003